Dirk Lehnick

About

Dirk Lehnick is the Head of Biostatistics and Methodology at the University of Lucerne, Switzerland. His research focuses on biostatistics, with recent articles examining adverse drug events related to immune checkpoint inhibitors, the effects of nitric oxide in preterm neonates, and iron metabolism in the context of inflammation. He has also contributed to studies on antibiotic exposure in newborns, as well as evaluations of pharmacokinetics and pharmacodynamics of biosimilars.